Advertisement

Primary Antibody Immunodeficiency and the Pregnant Patient

Published:October 27, 2022DOI:https://doi.org/10.1016/j.iac.2022.07.009

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Immunology and Allergy Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Tangye S.G.
        • Al-Herz W.
        • Bousfiha A.
        • et al.
        Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee.
        J Clin Immunol. 2020; 40: 24-64
        • Bousfiha A.
        • Jeddane L.
        • Picard C.
        • et al.
        Human inborn errors of immunity: 2019 update of the IUIS Phenotypical Classification.
        J Clin Immunol. 2020; 40: 66-81
        • Dancis J.
        • Lind J.
        • Oratz M.
        • et al.
        Placental transfer of proteins in human gestation.
        Am J Obstet Gynecol. 1961; 82: 167-171
        • Bonilla F.A.
        • Khan D.A.
        • Ballas Z.K.
        • et al.
        Practice parameter for the diagnosis and management of primary immunodeficiency.
        J Allergy Clin Immunol. 2015; 136 (e1181-1178): 1186-1205
        • Orange J.S.
        • Hossny E.M.
        • Weiler C.R.
        • et al.
        Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology.
        J Allergy Clin Immunol. 2006; 117: S525-S553
        • Friedmann D.
        • Goldacker S.
        • Peter H.H.
        • et al.
        Preserved cellular immunity upon influenza vaccination in most patients with common variable immunodeficiency.
        J Allergy Clin Immunol Pract. 2020; 8: 2332-2340 e2335
      1. CDC. Centers for Disease Control and Prevention: COVID-19 Vaccines While Pregnant or Breastfeeding.
        (Available at:) (Accessed 21 Dec, 2021)
      2. ACOG. American College of Obstetricians and Gynecologists (ACOG): COVID-19 Vaccination Considerations for Obstetric–Gynecologic Care.
        (Available at:) (Accessed Dec 21, 2021)
        • Shimabukuro T.T.
        • Kim S.Y.
        • Myers T.R.
        • et al.
        Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons.
        N Engl J Med. 2021; 384: 2273-2282
        • Goldshtein I.
        • Nevo D.
        • Steinberg D.M.
        • et al.
        Association between BNT162b2 vaccination and incidence of SARS-CoV-2 infection in pregnant women.
        JAMA. 2021; 326: 728-735
        • Dagan N.
        • Barda N.
        • Biron-Shental T.
        • et al.
        Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy.
        Nat Med. 2021; 27: 1693-1695
        • Gray K.J.
        • Bordt E.A.
        • Atyeo C.
        • et al.
        Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study.
        Am J Obstet Gynecol. 2021; 225: 303.e301-303.e317
        • Bookstaver P.B.
        • Bland C.M.
        • Griffin B.
        • et al.
        A review of antibiotic use in pregnancy.
        Pharmacotherapy. 2015; 35: 1052-1062
        • Pilmis B.
        • Jullien V.
        • Sobel J.
        • et al.
        Antifungal drugs during pregnancy: an updated review.
        J Antimicrob Chemother. 2015; 70: 14-22
        • Bruton O.C.
        Agammaglobulinemia.
        Pediatrics. 1952; 9: 722-728
      3. US Food and Drug Administration. Immune Globulins.
        (Available at:) (Accessed Sep 28, 2021)
        • Foundation I.D.
        Characteristics of immunoglobulin products used to treat primary immunodeficiencies (PI). In: Foundation ID, ed.
        (Available at:)
        • Imbach P.
        • Barandun S.
        • d'Apuzzo V.
        • et al.
        High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood.
        Lancet (London, England). 1981; 1: 1228-1231
        • Bussel J.B.
        • Kimberly R.P.
        • Inman R.D.
        • et al.
        Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura.
        Blood. 1983; 62: 480-486
        • Perez E.E.
        • Orange J.S.
        • Bonilla F.
        • et al.
        Update on the use of immunoglobulin in human disease: a review of evidence.
        J Allergy Clin Immunol. 2017; 139: S1-S46
        • D'Mello R.J.
        • Hsu C.D.
        • Chaiworapongsa P.
        • et al.
        Update on the use of intravenous immunoglobulin in pregnancy.
        NeoReviews. 2021; 22: e7-e24
        • Branch D.W.
        • Porter T.F.
        • Paidas M.J.
        • et al.
        Obstetric uses of intravenous immunoglobulin: successes, failures, and promises.
        J Allergy Clin Immunol. 2001; 108: S133-S138
        • Sorensen R.U.
        • Tomford J.W.
        • Gyves M.T.
        • et al.
        Use of intravenous immune globulin in pregnant women with common variable hypogammaglobulinemia.
        Am J Med. 1984; 76: 73-77
        • Berger M.
        • Cupps T.R.
        • Fauci A.S.
        High-dose immunoglobulin replacement therapy by slow subcutaneous infusion during pregnancy.
        JAMA. 1982; 247: 2824-2825
        • Gardulf A.
        • Andersson E.
        • Lindqvist M.
        • et al.
        Rapid subcutaneous IgG replacement therapy at home for pregnant immunodeficient women.
        J Clin Immunol. 2001; 21: 150-154
        • Więsik-Szewczyk E.
        • Jahnz-Różyk K.
        A case report of pregnancy in a patient with common variable immunodeficiency emphasizing the need for personalized immunoglobulin replacement.
        Medicine. 2018; 97: e12804
        • Cunningham-Rundles C.
        How I treat common variable immune deficiency.
        Blood. 2010; 116: 7-15
        • Egawa M.
        • Kanegane H.
        • Imai K.
        • et al.
        Intravenous immunoglobulin (IVIG) efficiency in women with common variable immunodeficiency (CVID) decreases significantly during pregnancy.
        J Maternal-Fetal Neonatal Med. 2019; 32: 3092-3096
        • Simister N.E.
        • Mostov K.E.
        An Fc receptor structurally related to MHC class I antigens.
        Nature. 1989; 337: 184-187
        • Firan M.
        • Bawdon R.
        • Radu C.
        • et al.
        The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of gamma-globulin in humans.
        Int Immunol. 2001; 13: 993-1002
        • Malek A.
        • Sager R.
        • Kuhn P.
        • et al.
        Evolution of maternofetal transport of immunoglobulins during human pregnancy.
        Am J Reprod Immunol. 1996; 36 (New York, NY : 1989): 248-255
        • Palmeira P.
        • Quinello C.
        • Silveira-Lessa A.L.
        • et al.
        IgG placental transfer in healthy and pathological pregnancies.
        Clin Develop Immunol. 2012; 2012: 985646
        • Costa-Carvalho B.T.
        • Vieria H.M.
        • Dimantas R.B.
        • et al.
        Transfer of IgG subclasses across placenta in term and preterm newborns.
        Braz J Med Biol Res. 1996; 29: 201-204
        • Skoda-Smith S.
        • Torgerson T.R.
        • Ochs H.D.
        Subcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency disease.
        Ther Clin Risk Manag. 2010; 6: 1-10
      4. Immune globulin (Intravenous, subcutaneous, and intramuscular). Drug information, 2021 (Accessed)
        • Bonilla F.A.
        Intravenous immunoglobulin: adverse reactions and management.
        J Allergy Clin Immunol. 2008; 122: 1238-1239
        • Quinti I.
        • Soresina A.
        • Agostini C.
        • et al.
        Prospective study on CVID patients with adverse reactions to intravenous or subcutaneous IgG administration.
        J Clin Immunol. 2008; 28: 263-267
        • Cunningham-Rundles C.
        Hematologic complications of primary immune deficiencies.
        Blood Rev. 2002; 16: 61-64
        • Sheikhbahaei S.
        • Sherkat R.
        • Camacho-Ordonez N.
        • et al.
        Pregnancy, child bearing and prevention of giving birth to the affected children in patients with primary immunodeficiency disease; a case-series.
        BMC Pregnancy Childbirth. 2018; 18: 299
      5. FDA. Safety & Availability (Biologics) > FDA Safety Communication: New boxed warning for thrombosis related to human immune globulin products. 2013.
        (Available at:) (Accessed Dec 15, 2021)
        • Brown H.C.
        • Ballas Z.K.
        Acute thromboembolic events associated with intravenous immunoglobulin infusion in antibody-deficient patients.
        J Allergy Clin Immunol. 2003; 112: 797-799